ArticleTrials2025
Effect of different targeted tidal volumes during high-frequency oscillation with volume-targeted ventilation on cerebral blood flow velocity and cardiac output: study protocol for a randomised crossover study.
Article in Trials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06719284 (Crossover Study of the Cerebral Blood Flow and Cardiac Output At Different Targeted Tidal Volumes During High Frequency Oscillation with Volume Targeted Ventilation), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Crossover Study of the Cerebral Blood Flow and Cardiac Output At Different Targeted Tidal Volumes During High Frequency Oscillation with Volume Targeted Ventilation (HFO&VTV)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHigh frequency oscillation (HFO) is a lung protective ventilation strategy for newborn infants due to the small tidal volume delivery at fast frequencies, but has been associated with an increased risk of brain injury. High-frequency oscillation with volume-targeted ventilation (HFO&VTV) is a new mode of HFO that applies a targeted tidal volume (VThf) set by the clinician and achieves less fluctuations of carbon dioxide levels and therefore reduces the risk of brain injury. The optimal starting VThf values, however, have not been explored to date. This study investigates the optimum starting settings in newborn infants receiving HFO by comparing the cerebral blood flow velocity and cardiac output at different tidal volume targets of HFO&VTV.
methodsThis randomised crossover trial performed at a single tertiary neonatal unit will be recruiting 25 infants of any gestation and at any postnatal age receiving HFO. Each infant will receive three targeted tidal volumes on HFO&VTV in random order with control periods in between. The resistive index (RI) as an indicator of cerebral blood flow in term-born infants and the cardiac output for all infants in the study will be assessed in each period. The primary outcome will be the reduction in the RI that will be measured on term-born infants using the anterior cerebral artery Doppler. The secondary outcome will be the improvement in cardiac output that will be assessed in all infants with bedside ECHO. The study will be performed following informed parental consent and was approved by the London-Hampstead research ethics committee (Protocol version 2, 22/01/25). DISCUSSION: This trial will investigate the effect of HFO&VTV on cerebral blood flow velocity and cardiac output to further elucidate the optimal volume targeting range in newborn infants.
trial registrationClinicalTrials.Gov, NCT06719284 , registered on 04/12/2024.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.